Role of Growth Differentiation Factor 15 in Lung Disease and Senescence: Potential Role Across the Lifespan

Abstract

Growth Differentiation Factor 15 (GDF15) is a divergent member of transforming growth factor-beta (TGF-β) superfamily and is ubiquitously expressed, under normal physiological conditions. GDF15 expression increases during many pathological states and serves a marker of cellular stress. GDF15 has multiple and even paradoxical roles within a pathological condition, as its effects can be dose- and time-dependent and vary based on the targeted tissues and downstream pathways. GDF15 has emerged as one of the most recognized proteins as part of the senescence associated secretory phenotype. Cellular senescence plays a major role in many lung diseases across the life-span from bronchopulmonary dysplasia in the premature neonate to COPD and idiopathic pulmonary fibrosis in aged adults. GDF15 levels have been reported to be as a useful biomarker in chronic obstructive pulmonary disease, lung fibrosis and pulmonary arterial hypertension and predict disease severity, decline in lung function and mortality. Glial-cell-line-derived neurotrophic factor family receptor alpha-like (GFRAL) in the brain stem has been identified as the only validated GDF15 receptor and mediates GDF15-mediated anorexia and wasting. The mechanisms and pathways by which GDF15 exerts its pulmonary effects are being elucidated. GDF15 may also have an impact on the lung based on the changes in circulating levels or through the central action of GDF15 activating peripheral metabolic changes. This review focuses on the role of GDF15 in different lung diseases across the lifespan and its role in cellular senescence.

Pharmacological Inhibition of CBP/p300 Blocks Estrogen Receptor Alpha (ERα) Function through Suppressing Enhancer H3K27 Acetylation in Luminal Breast Cancer

“…Indeed, MCF-7 cells treated with A-485, GNE-049 and fulvestrant show marked long-term growth inhibition after drug washout ( Figure 7 D). A-485 upregulated expression of genes involved in senescence (e.g., ZFP36, EGR1, and GDF15 [ 77 , 78 , 79 ]) in our microarray data of A-485-treated MCF-7 cells ( Figure 7 E). Long-term A-485 treatment also increased β-galactosidase activity, a commonly used senescence marker, in MCF-7 cells ( Figure 7 F).…”

Deconstructing replicative senescence heterogeneity of human mesenchymal stem cells at single cell resolution reveals therapeutically targetable senescent cell sub-populations

“…Expression of MMPs is associated with the production of reactive oxygen species (ROS) that drive the emergence of senescence and age-associated disease [72]. GDF15 is involved in the stress response program of cells following cellular injury, and its increased gene expression is associated with age-associated states such as tissue hypoxia, inflammation and oxidative stress [73] and was previously found to contribute to radiation-induced senescence through the ROS-mediated p16 pathway in human endothelial cells [74]. Another gene of note amongst the top 10 highly connected genes in cluster 1 (the senescence state, T2) is SFRP1, a gene that is commonly over expressed in senescent cells exposed to DNA damage or oxidative stress [75].…”

GDF15: an emerging modulator of immunity and a strategy in COVID-19 in association with iron metabolism

“…GDF15 has multiple and even paradoxical roles within a pathological condition. Its effects can be dose and time related, and dependent of the targeted tissues [31]. GDF15 acts as a 'protective' cytokine, although, in certain conditions, it causes endothelial dysfunction by impairing vascular contraction and relaxation, potentially inducing microvascular disease and causing organ function to deteriorate [32].…”